Literature DB >> 9927402

Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions.

M Gwechenberger1, L H Mendoza, K A Youker, N G Frangogiannis, C W Smith, L H Michael, M L Entman.   

Abstract

BACKGROUND: Previous work from our laboratory demonstrated that interleukin (IL)-6 plays a potentially critical role in postreperfusion myocardial injury and is the major cytokine responsible for induction of intracellular adhesion molecule (ICAM)-1 on cardiac myocytes during reperfusion. Myocyte ICAM-1 induction is necessary for neutrophil-associated myocyte injury. We have previously demonstrated the induction of IL-6 in the ischemic myocardium, and the current study addresses the cells of origin of IL-6. METHODS AND
RESULTS: In the present study, we combined Northern blot analysis and in situ hybridization to demonstrate IL-6 gene expression in cardiac myocytes. Isolated ventricular myocytes were stimulated with tumor necrosis factor-alpha, IL-1beta, lipopolysaccharide, preischemic lymph, and postischemic lymph. Unstimulated myocytes showed no significant IL-6 mRNA expression. Myocytes stimulated with preischemic lymph showed minimal or no IL-6 mRNA expression, whereas myocytes stimulated with tumor necrosis factor-alpha, IL-1beta, lipopolysaccharide, or postischemic lymph showed a strong IL-6 mRNA induction. Northern blot with ICAM-1 probe revealed ICAM-1 expression under every condition that demonstrated IL-6 induction. We then investigated the expression of IL-6 mRNA in our canine model of ischemia and reperfusion. Cardiac myocytes in the viable border zone of a myocardial infarction exhibited reperfusion-dependent expression of IL-6 mRNA within 1 hour after reperfusion. Mononuclear cells infiltrate the border zone and express IL-6 mRNA.
CONCLUSIONS: Isolated cardiac myocytes produce IL-6 mRNA in response to several cytokines as well as postischemic cardiac lymph. In addition to its production by inflammatory cells, we demonstrate that IL-6 mRNA is induced in myocytes in the viable border zone of a myocardial infarct. The potential roles of IL-6 in cardiac myocytes in an infarct border are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927402     DOI: 10.1161/01.cir.99.4.546

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  86 in total

Review 1.  Cytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance.

Authors:  K Yamauchi-Takihara; T Kishimoto
Journal:  Int J Exp Pathol       Date:  2000-02       Impact factor: 1.925

Review 2.  Apoptosis in myocardial ischaemia and infarction.

Authors:  P A J Krijnen; R Nijmeijer; C J L M Meijer; C A Visser; C E Hack; H W M Niessen
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

3.  Circulating interleukin-6 significantly correlates to thyroid hormone in acute myocardial infarction but not in chronic heart failure.

Authors:  M Nishino; T Kimura; T Kanda; N Kotajima; A Yoshida; A Kuwabara; K Tamama; Y Fukumura; I Kobayashi
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

4.  gp130 cytokines stimulate proteasomal degradation of tyrosine hydroxylase via extracellular signal regulated kinases 1 and 2.

Authors:  Xiao Shi; Beth A Habecker
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

5.  Cardiac ischemia-reperfusion regulates sympathetic neuropeptide expression through gp130-dependent and independent mechanisms.

Authors:  Eric N Alston; Diana C Parrish; Wohaib Hasan; Kevin Tharp; Laura Pahlmeyer; Beth A Habecker
Journal:  Neuropeptides       Date:  2010-10-28       Impact factor: 3.286

6.  STAT3 integrates cytokine and neurotrophin signals to promote sympathetic axon regeneration.

Authors:  Michael J Pellegrino; Beth A Habecker
Journal:  Mol Cell Neurosci       Date:  2013-07-03       Impact factor: 4.314

Review 7.  Cardiac biomarkers: new tools for heart failure management.

Authors:  Navaid Iqbal; Bailey Wentworth; Rajiv Choudhary; Alejandro De La Parra Landa; Benjamin Kipper; Arrash Fard; Alan S Maisel
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

8.  Nuclear factor kappa B in patients with a history of unstable angina: case re-opened.

Authors:  Chiara Mozzini; Ulisse Garbin; Chiara Stranieri; Giulia Salandini; Giancarlo Pesce; Anna Maria Fratta Pasini; Luciano Cominacini
Journal:  Intern Emerg Med       Date:  2018-06-01       Impact factor: 3.397

9.  Glycyrrhizin protects rat heart against ischemia-reperfusion injury through blockade of HMGB1-dependent phospho-JNK/Bax pathway.

Authors:  Chang-lin Zhai; Mei-qi Zhang; Yun Zhang; Hong-xia Xu; Jing-min Wang; Gui-peng An; Yuan-yuan Wang; Li Li
Journal:  Acta Pharmacol Sin       Date:  2012-10-15       Impact factor: 6.150

Review 10.  The varying faces of IL-6: From cardiac protection to cardiac failure.

Authors:  Jillian A Fontes; Noel R Rose; Daniela Čiháková
Journal:  Cytokine       Date:  2015-01-31       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.